Drugs / Huang-Lian-Jie-Du-Tang
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02467647 | Jan 2015 → Dec 2018 | plasma cell myeloma | Wuhan University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Huang-Lian-Jie-Du-Tang | “Phase 1 Study of the Effects of Huang-Lian-Jie-Du-Tang（HLJDT) on the Survival of Patients With Multiple Myeloma in Maintain Therapy” NCT02467647 ↗ |
| Known as | HLJDT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02467647 ↗ |